Resource Logo
NLM AIDSLINE

High-dose intravenous immunoglobulins in the treatment of adolescent and adult HIV-infected hemophiliacs.




 

Clin Investig. 1994 Jan;72(2):122-6. Unique Identifier : AIDSLINE

In children infected with human immunodeficiency virus (HIV) placebo-controlled trials with intravenous immunoglobulins have resulted in a significant reduction in morbidity; however, the results of small trials in adolescents and adults have been inconsistent. In this study 17 HIV-infected hemophiliacs aged 9-30 years were treated with monthly intravenous immunoglobulins for an average of 32 months. At the end of the study, 8 years after the HIV infection, three patients (18%) had progressed to the acquired immunodeficiency syndrome (AIDS), and the average decrease in CD4 cells was 81 cells/microliter per year. The natural history of HIV infection in hemophiliacs in this age group shows a manifestation rate of AIDS between 11% and 26% 6-8 years after seroconversion and an average yearly decrease in CD4 lymphocytes of 68-110 cells/microliters. In conclusion, we observed no difference either in the manifestation rate of AIDS or in prognostic markers in this small cohort of HIV-infected hemophiliacs treated for more than 30% of their latency period with intravenous immunoglobulins compared to the well-documented natural history of HIV-infected hemophiliacs. However, none of the patients developed severe bacterial infections during the study period.

Adolescence Adult AIDS-Related Opportunistic Infections/PREVENTION & CONTROL Blood Transfusion/ADVERSE EFFECTS Child Hemophilia/*COMPLICATIONS/DRUG THERAPY Human HIV Infections/*DRUG THERAPY/ETIOLOGY Immunoglobulins, Intravenous/*ADMINISTRATION & DOSAGE CLINICAL TRIAL JOURNAL ARTICLE



 




Information in this article was accurate in August 30, 1994. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.